View of Characterization of A Dual-Drug Liposomal Nanoformulation of Metformin Hydrochloride and Canagliflozin Hemihydrate for Sustained Oral Delivery.

Return to Article Details Characterization of A Dual-Drug Liposomal Nanoformulation of Metformin Hydrochloride and Canagliflozin Hemihydrate for Sustained Oral Delivery. Download Download PDF